Device Review Improvements Not Expected Until FY 2005 Under MDUFMA
This article was originally published in The Silver Sheet
Executive Summary
MEDICAL DEVICE USER FEES are expected to lead to a 25% reduction in premarket review times at the end of five years. Under the "Medical Device User Fee and Modernization Act," signed by President Bush Oct. 26, manufacturers will pay FDA a range of fees – from $154,000 for PMA reviews to $2,187 for 510(k)s – in return for the agency’s commitment to meet increasingly strict cycle review and decision goals as the program matures. Fees will fund a number of review-related activities, including pre-approval inspections, clinical trial monitoring and standards development. The Center for Devices and Radiological Health has assigned various teams to begin implementing the new program and to assess how user fees will affect operations across the center
You may also be interested in...
MDUFA V: US FDA Staff Could See September Lay-Off Notices
The notices normally would go out on 1 August, but unspent user fee funds may be able to sustain work for a few weeks if the program expires.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.